Overview / Abstract: |
Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main subtypes, is a chronic relapsing condition characterized by an overly active immune response in the gut, resulting in bowel inflammation and ulceration. Given the increasing prevalence of disease and influx of available biologics and small molecule therapies, gastroenterology fellows can benefit from ongoing education regarding the diagnosis, classification, and evidence-based management of patients with IBD. In the Best of IBD Summit, available in 2 parts, expert clinicians discuss the latest updates in diagnosing and managing IBD. Faculty will evaluate the safety and efficacy of current and emerging therapies and discuss optimal positioning of available agents. |
Expiration |
Feb 27, 2024 |
Discipline(s) |
Physician CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
2.25 |
Accreditation |
This continuing education activity is provided by Vindico Medical Education. |
Presenters / Authors / Faculty |
David T. Rubin, MD; Corey A. Siegel, MD, MS; Maria T. Abreu, MD; Jessica Caron, MS; Marla C. Dubinsky, MD; Stephen B. Hanauer, MD; Edward V. Loftus, Jr., MD; Millie D. Long, MD, MPH; Miguel Regueiro, MD |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc. |
Keywords / Search Terms |
Vindico Medical Education IBD, bowel disease, strategies Free CE CME |